News and Reports

This Award recognizes a team or State official for using evidence to innovate and achieve improvements for their State populations.

This presentation examines the ways in which state Medicaid agencies engage their clinical staff. It examines different clinical staff structures, leadership roles, and disciplines, the range of responsibilities and strategic portfolios held by clinical staff, and how clinical expertise can drive value for the agency. It also includes considerations for how states might optimize, extend, […]

The 2025 Oregon Child Integrated Dataset (OCID) legislative report is now available! Launched by the Oregon legislature in 2019, OCID is an objective data resource for policymakers to improve outcomes for the state’s children and families through evidence drawn from across traditional agency data silos. The report highlights OCID’s work for the last two years which included […]

We believe all states need access to high-quality evidence from reliable sources now more than ever, so we created the Evidence Synthesis Series to share information from recent research reports. We hope you will join us!  If you want to hear more about this, please subscribe to receive more information.   Webinar 1: The Role […]

Click here to download our 2024 Annual Report, “The Certainty of Evidence in Uncertain Times.”

The MED DME Workgroup Tool: Medicaid Coverage of Enclosed Beds examines the use of enclosed beds—specialized safety devices designed to prevent injury for children with conditions like autism spectrum disorder (ASD) or developmental disabilities. It highlights the rising use of enclosed beds—specialized safety devices for children with conditions like autism spectrum disorder (ASD) or developmental […]

The MED Policy Brief: Enhancing Global Billing Practices for Medicaid Pregnancy Services examines the use of global obstetric billing in 37 state Medicaid programs, a bundled payment model covering prenatal, delivery, and postpartum care. It identifies practical challenges, such as inadequate compensation for complex pregnancies, limited data transparency due to bundled coding, and care fragmentation […]

The Center for Evidence-based Policy is excited to announce the release of the second set of briefs from its Medicaid Evidence and Review of Cost Initiative (MERCI) project. Focused on drugs approved through the FDA’s accelerated approval pathway, each MERCI drug brief is a case study which includes the clinical trial evidence used for FDA […]

The Centers for Medicare & Medicaid Services (CMS) Interoperability and Prior Authorization final rule establishes new prior authorization requirements that apply broadly to “items and services” other than drugs. State Medicaid and CHIP programs and managed care plans must meet prior authorization policy requirements by 2026 and must implement new application programming interface (API) technologies […]

Susan Stuard from the Center recently authored a new blog on the Medicaid Evidence and Review of Cost Initiative (MERCI) project for the Milbank Memorial Fund.  The article highlights issues with the FDA’s accelerated drug approval process affecting Medicaid coverage. Medicaid must cover all FDA-approved drugs, even with limited trial data, increasing risks for patients. […]